Thrombin aptasensing with inherently electroactive graphene oxide nanoplatelets as labels

Adeline Huiling Loo, Alessandra Bonanni, Martin Pumera

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Graphene and its associated materials are commonly used as the transducing platform in biosensing. We propose a different approach for the application of graphene in biosensing. Here, we utilized graphene oxide nanoplatelets as the inherently electroactive labels for the aptasensing of thrombin. The basis of detection lies in the ability of graphene oxide to be electrochemically reduced, thereby providing a well-defined reduction wave; one graphene oxide nanoplatelet of dimension 50 × 50 nm can provide a reduction signal by accepting ∼22 000 electrons. We demonstrate that by using graphene oxide nanoplatelets as an inherently electroactive label, we can detect thrombin in the concentration range of 3 pM-0.3 μM, with good selectivity of the aptamer towards interferences by bovine serum albumin, immunoglobulin G and avidin. Therefore, the inherently electroactive graphene oxide nanoplatelets are a material which can serve as an electroactive label, in a manner similar to metallic nanoparticles.

Original languageEnglish
Pages (from-to)4758-4762
Number of pages5
JournalNanoscale
Volume5
Issue number11
DOIs
Publication statusPublished - 2013 Jun 7

Fingerprint

Graphite
Thrombin
Oxides
Graphene
Labels
Avidin
Bovine Serum Albumin
Immunoglobulin G
Nanoparticles
Electrons

All Science Journal Classification (ASJC) codes

  • Materials Science(all)

Cite this

Loo, Adeline Huiling ; Bonanni, Alessandra ; Pumera, Martin. / Thrombin aptasensing with inherently electroactive graphene oxide nanoplatelets as labels. In: Nanoscale. 2013 ; Vol. 5, No. 11. pp. 4758-4762.
@article{be42107bed844f55869b9a5c09407e30,
title = "Thrombin aptasensing with inherently electroactive graphene oxide nanoplatelets as labels",
abstract = "Graphene and its associated materials are commonly used as the transducing platform in biosensing. We propose a different approach for the application of graphene in biosensing. Here, we utilized graphene oxide nanoplatelets as the inherently electroactive labels for the aptasensing of thrombin. The basis of detection lies in the ability of graphene oxide to be electrochemically reduced, thereby providing a well-defined reduction wave; one graphene oxide nanoplatelet of dimension 50 × 50 nm can provide a reduction signal by accepting ∼22 000 electrons. We demonstrate that by using graphene oxide nanoplatelets as an inherently electroactive label, we can detect thrombin in the concentration range of 3 pM-0.3 μM, with good selectivity of the aptamer towards interferences by bovine serum albumin, immunoglobulin G and avidin. Therefore, the inherently electroactive graphene oxide nanoplatelets are a material which can serve as an electroactive label, in a manner similar to metallic nanoparticles.",
author = "Loo, {Adeline Huiling} and Alessandra Bonanni and Martin Pumera",
year = "2013",
month = "6",
day = "7",
doi = "10.1039/c3nr00511a",
language = "English",
volume = "5",
pages = "4758--4762",
journal = "Nanoscale",
issn = "2040-3364",
publisher = "Royal Society of Chemistry",
number = "11",

}

Thrombin aptasensing with inherently electroactive graphene oxide nanoplatelets as labels. / Loo, Adeline Huiling; Bonanni, Alessandra; Pumera, Martin.

In: Nanoscale, Vol. 5, No. 11, 07.06.2013, p. 4758-4762.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Thrombin aptasensing with inherently electroactive graphene oxide nanoplatelets as labels

AU - Loo, Adeline Huiling

AU - Bonanni, Alessandra

AU - Pumera, Martin

PY - 2013/6/7

Y1 - 2013/6/7

N2 - Graphene and its associated materials are commonly used as the transducing platform in biosensing. We propose a different approach for the application of graphene in biosensing. Here, we utilized graphene oxide nanoplatelets as the inherently electroactive labels for the aptasensing of thrombin. The basis of detection lies in the ability of graphene oxide to be electrochemically reduced, thereby providing a well-defined reduction wave; one graphene oxide nanoplatelet of dimension 50 × 50 nm can provide a reduction signal by accepting ∼22 000 electrons. We demonstrate that by using graphene oxide nanoplatelets as an inherently electroactive label, we can detect thrombin in the concentration range of 3 pM-0.3 μM, with good selectivity of the aptamer towards interferences by bovine serum albumin, immunoglobulin G and avidin. Therefore, the inherently electroactive graphene oxide nanoplatelets are a material which can serve as an electroactive label, in a manner similar to metallic nanoparticles.

AB - Graphene and its associated materials are commonly used as the transducing platform in biosensing. We propose a different approach for the application of graphene in biosensing. Here, we utilized graphene oxide nanoplatelets as the inherently electroactive labels for the aptasensing of thrombin. The basis of detection lies in the ability of graphene oxide to be electrochemically reduced, thereby providing a well-defined reduction wave; one graphene oxide nanoplatelet of dimension 50 × 50 nm can provide a reduction signal by accepting ∼22 000 electrons. We demonstrate that by using graphene oxide nanoplatelets as an inherently electroactive label, we can detect thrombin in the concentration range of 3 pM-0.3 μM, with good selectivity of the aptamer towards interferences by bovine serum albumin, immunoglobulin G and avidin. Therefore, the inherently electroactive graphene oxide nanoplatelets are a material which can serve as an electroactive label, in a manner similar to metallic nanoparticles.

UR - http://www.scopus.com/inward/record.url?scp=84878117319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878117319&partnerID=8YFLogxK

U2 - 10.1039/c3nr00511a

DO - 10.1039/c3nr00511a

M3 - Article

C2 - 23604556

AN - SCOPUS:84878117319

VL - 5

SP - 4758

EP - 4762

JO - Nanoscale

JF - Nanoscale

SN - 2040-3364

IS - 11

ER -